200228_Appendix 4D & Half Year Report Categories: Financial Reports 2020, News & Announcements 2020By PharmAustFebruary 28, 2020Related postsDecember 31, Top 20 ShareholdersJanuary 4, 2021December 23, PharmAust Commences MPL Manufacture for Human Clinical TrialsDecember 23, 2020December 22, PharmAust Set to Commence Phase IIb Anticancer Canine TrialDecember 22, 2020December 21, Epichem Awarded DNDi ExtensionDecember 21, 2020December 4, Issued CapitalDecember 4, 2020November 30, Top 20 ShareholdersDecember 1, 2020